Clinical Trials Directory

Trials / Completed

CompletedNCT02329353

Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers

Clinical And Microbiological Analysis Of Orally Administered Lactobacillus Probiotic Lozenges In Chronic Periodontitis Patients Among Smokers And Non-smokers And Its Correlation With Clinical Parameters - A Clinico-Microbiological Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Next Gen Pharma India Pvt. Ltd. · Industry
Sex
All
Age
30 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Periodontitis is one of the most common chronic inflammatory disease with the etiology of bacterial plaque and is associated with a number of putative bacterial species. The periodontal destruction is substantially mediated by the host, driven by the bacterial challenge. The presence of pathogenic bacteria with the absence of so-called "beneficial bacteria" and the susceptibility of the host are the main aetiological factors of periodontal diseases.

Conditions

Interventions

TypeNameDescription
DRUGLactobacillus brevis CD2 LozengesEach lozenge contains not less than 1 billion Colony forming unit of Lactobacillus brevis CD2

Timeline

Start date
2015-02-01
Primary completion
2016-11-01
Completion
2016-12-01
First posted
2014-12-31
Last updated
2017-01-10

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02329353. Inclusion in this directory is not an endorsement.

Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers (NCT02329353) · Clinical Trials Directory